MIXED ANTHRAX VACCINE

FIELD: medicine. SUBSTANCE: vaccine has living spores of noncapsule strain of Bac. anthracis ê and protective antigen of Bac. anthracis. A single dose of commercial variant of vaccine has: living spores of strain Bac. anthracis ê - 40-60 mln; protective antigen of Bac. anthracis - 30-40 êä50 and alu...

Full description

Saved in:
Bibliographic Details
Main Authors SELIVANENKO G.M, SUPOTNITSKIJ M.V, LITUSOV N.V, KRAVETS I.D, SADOVAJA E.A, ELAGIN G.D, KHARECHKO G.S, VASIL'EV P.G, SADOVOJ N.V
Format Patent
LanguageEnglish
Published 20.07.1998
Edition6
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:FIELD: medicine. SUBSTANCE: vaccine has living spores of noncapsule strain of Bac. anthracis ê and protective antigen of Bac. anthracis. A single dose of commercial variant of vaccine has: living spores of strain Bac. anthracis ê - 40-60 mln; protective antigen of Bac. anthracis - 30-40 êä50 and aluminium hydroxide gel 2.5 mg, not above, where êä50 - mean effective immunizing unit for albino mice. Vaccination is carried out one time per a year, expressing immunity is formed in 7-10 days. Immunization at antibiotic therapy background is possible. EFFECT: improved quality of vaccine. 5 tblt FIELD: medicine. SUBSTANCE: vaccine has living spores of noncapsule strain of Bac. anthracis æÆê and protective antigen of Bac. anthracis. A single dose of commercial variant of vaccine has: living spores of strain Bac. anthracis æÆê - 40-60 mln; protective antigen of Bac. anthracis - 30-40 êä50 and aluminium hydroxide gel 2.5 mg, not above, where êä50 - mean effective immunizing unit for albino mice. Vaccination is carried out one time per a year, expressing immunity is formed in 7-10 days. Immunization at antibiotic therapy background is possible. EFFECT: improved quality of vaccine. 5 tblt
Bibliography:Application Number: SU19925060604